Seer (SEER) Non-Current Assets (2020 - 2026)
Seer (SEER) recorded quarterly Non-Current Assets of $90.5 million in Q1 2026, down 4.24% quarter-over-quarter from $94.5 million in Q4 2025, and down 1.58% on a YoY basis from $92.0 million in Q1 2025.
Seer (SEER) Non-Current Assets (2020 - 2026) Analysis & Trends
Seer's Non-Current Assets history runs 7 years deep, the most recent figure standing at $90.5 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 1.58% year-over-year to $90.5 million; the TTM figure through Mar 2026 stood at $376.2 million (down 12.82% YoY), while the FY2025 annual figure was $94.5 million, down 16.53% from the prior year.
- Non-Current Assets was $90.5 million for Q1 2026 at Seer, down from $94.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $125.8 million in Q2 2023 to a low of $49.5 million in Q2 2022.
- Historically, Non-Current Assets has averaged $91.9 million across 5 years, with a median of $96.8 million in 2025.
- Biggest YoY gain for Non-Current Assets was 640.58% in 2022; the steepest drop was 58.45% in 2022.
- A 5-year view of Non-Current Assets shows it stood at $52.9 million in 2022, then soared by 99.74% to $105.8 million in 2023, then climbed by 7.11% to $113.3 million in 2024, then decreased by 16.53% to $94.5 million in 2025, then decreased by 4.24% to $90.5 million in 2026.
- The last three Non-Current Assets figures came in at $90.5 million (Q1 2026), $94.5 million (Q4 2025), and $94.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 62,953.78 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 39.71 Mn |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | 90.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.54 Mn |
| Dec 31, 2025 | 94.55 Mn |
| Sep 30, 2025 | 94.25 Mn |
| Jun 30, 2025 | 96.85 Mn |
| Mar 31, 2025 | 91.99 Mn |
| Dec 31, 2024 | 113.27 Mn |
| Sep 30, 2024 | 119.32 Mn |
| Jun 30, 2024 | 106.92 Mn |
| Mar 31, 2024 | 97.81 Mn |
| Dec 31, 2023 | 105.76 Mn |
| Sep 30, 2023 | 98.73 Mn |
| Jun 30, 2023 | 125.81 Mn |
| Mar 31, 2023 | 105.41 Mn |
| Dec 31, 2022 | 52.95 Mn |
| Sep 30, 2022 | 49.74 Mn |
| Jun 30, 2022 | 49.54 Mn |
| Mar 31, 2022 | 69.63 Mn |
| Dec 31, 2021 | 127.44 Mn |
| Sep 30, 2021 | 13.57 Mn |
| Jun 30, 2021 | 11.72 Mn |